Croda International Plc ispartnering with academia to provide valued material for global vaccine developments around Covid-19.   During the emergence of the pandemic, Croda has actively reached out to research groups around the world, offering free of charge material and expertise. Croda's saponin-based and aluminium-based vaccine adjuvants are actively being used and are now part of prototype vaccines.   With over 80 years’ experience in this area, the team are well placed to support t...